Hosted By
Program Overview
IN-PERSON & LIVE VIRTUAL CONFERENCE
The Advanced
Heart Failure Summit: From Cardiogenic Shock to Heart Transplant is a full-day,
multidisciplinary program dedicated to the evolving management of advanced
heart failure across the entire spectrum of care. This comprehensive symposium
brings together leaders in cardiology, cardiac surgery, mechanical circulatory
support, critical care, and transplantation to explore cutting-edge strategies,
emerging technologies, and real-world clinical decision-making.
The
program begins with an in-depth review of cardiogenic shock, including modern
SCAI classification, phenotyping, risk stratification, device selection,
advanced ECMO and Impella approaches, and complex case discussions. The morning
continues with a forward-looking session on LVAD therapy, highlighting
optimization of durable MCS, arrhythmia management, anticoagulation, prevention
of driveline infection, use of CardioMEMS and novel monitoring tools, and
future innovations in device technology.
Following
a keynote address on training the next generation of Advanced HF specialists,
the afternoon focuses on the latest advances in heart transplantation,
including noninvasive monitoring (cfDNA, TTVR), tissue gene expression,
desensitization strategies, management of AMR and CAV, multiorgan transplant
considerations, transplant for amyloid cardiomyopathy, malignancy
post-transplant, and CMV resistance. The day concludes with a high-impact
case-based session featuring challenging scenarios in LVAD and transplant care,
followed by a poster session and networking reception.
The
symposium provides an unparalleled opportunity for clinicians, surgeons,
researchers, trainees, and allied health professionals to deepen expertise,
share experience, and advance excellence in the care of patients with advanced
heart failure.
Learning Objectives
By the end of the symposium, participants will be able to:
- Describe cardiogenic shock phenotypes, risk stratificiation, and modern device-based management strategies.
- Understand approaches to LVAD therapy, including optimization, arrhythmia management, anticoagulation, and prevention of complications.
- Evaluate contemporary heart transplant care, including noninvasive monitoring, rejection management, and outcomes in complex paient populations.
- Analyze complex clinical cases to improve multidisciplinary decision-making in advanced heart failure care.
- Incorporate emerging technologies and best practices to optimize patient outcomes across the continuum of advanced heart failure.
Accreditation Statement
In
support of improving patient care, this activity has been planned and
implemented by Amedco LLC and Columbia University. Amedco LLC is jointly
accredited by the Accreditation Council for Continuing Medical
Education (ACCME), the Accreditation Council for Pharmacy Education
(ACPE), and the American Nurses Credentialing Center (ANCC), to provide
continuing education for the healthcare team. Professions in scope for this activity are listed below. Amedco Joint Accreditation Provider Number: 4008163.
Physicians (ACCME) Credit Designation Statement
Amedco LLC designates this live activity for a maximum of XX AMA PRA Category 1 Credits™ for physicians. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
